Clinical Trials Browser

Phase 2 × Laryngeal Neoplasms × camrelizumab × Clear all

NCT07400094 2026-02-10

NeoCamre-HN

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Mouth Neoplasms